ADAR1 Capital Management »

Macrogenics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $116k 40k 2.89

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Macrogenics

Armistice Capital
Vanguard Group
Renaissance Technologies
Millennium Management
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Bank of America Corporation
RA Capital Management
Daniel D. Thurber
Marshall Wace
Vanguard Portfolio Management
BlackRock
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Macrogenics